Atorvastatin affects several angiogenic mediators in human endothelial cells

Endothelium: Journal of Endothelial Cell Research

Volumn 12, Issue 5-6, 2005, Pages 233-241

  Dulak, Józef ^a   Loboda, Agnieszka ^a   Jazwa, Agnieszka ^a   Zagorska, Anna ^a   Dörler, Jacob ^b   Alber, Hannes ^b   Dichtl, Wolfgang ^b   Weidinger, Franz ^b   Frick, Matthias ^b   Jozkowicz, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Atherosclerosis; Cancer; Heme oxygenase 1; Interleukin 8; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 2; ATORVASTATIN; CHEMOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSPONDIN 1; UROKINASE;

ANGIOGENESIS; ARTICLE; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PLEIOTROPY; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PYRROLES;

EID: 33646849896     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320500476559     Document Type: Article

References (56)

1. Alber, H. and Dulak, J and Frick, M and Dichtl, W and Schwarzacher, S. and Pachinger, O and Weidinger, F. (2002) Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease Journal of American College of Cardiology, 39, pp. 1951-1955. [CSA]
2. Alber, H and Frick, M and Dulak, J and Dörler, J and Zwick, R and Dichtl, W and Pachinger, O and Weidinger, F. (2005) Vascular endothelial growth factor (VEGF) plasma levels in coronary artery disease Heart, 91, pp. 365-366.
3. Arnoletti, J. and Albo, D and Granick, M. and Solomon, M. and Castiglioni, A and Rothman, V. and Tuszynski, G. (1995) Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells Cancer, 76, pp. 998-1005. [PUBMED] [INFOTRIEVE] [CSA]
4. Assmus, B and Urbich, C and Aicher, A and Hofmann, W. and Haendeler, J and Rossig, L and Spyridopoulos, I and Zeiher, A. and Dimmeler, S. (2003) HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes Circulation Research, 92, pp. 1049-1055. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
5. Bertin, N and Clezardin, P and Kubiak, R and Frappart, L. (1997) Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: Correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia Cancer Research, 57, pp. 396-399. [PUBMED] [INFOTRIEVE] [CSA]
6. Brouet, A and Sonveaux, P and Dessy, C and Moniotte, S and Balligand, J. and Feron, O. (2001) Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins Circulation Research, 89, pp. 866-873. [PUBMED] [INFOTRIEVE] [CSA]
7. Clezardin, P and Frappart, L and Clerget, M and Pechoux, C and Delmas, P. (1993) Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast Cancer Research, 53, pp. 1421-1430. [PUBMED] [INFOTRIEVE] [CSA]
8. de Fraipont, F and Nicholson, A. and Feige, J. and Van Meir, E. (2001) Thrombospondins and tumor angiogenesis Trends in Molecular Medicine, 7, pp. 401-407. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
9. Deramaudt, B. and Braunstein, S and Remy, P and Abraham, N. (1998) Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis Journal of Cellular Biochemistry, 68, pp. 121-127. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
10. Desager, J. and Horsmans, Y. (1996) Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors Clinical Pharmacokinetics, 31, pp. 348-371. [PUBMED] [INFOTRIEVE] [CSA]
11. Dimmeler, S and Aicher, A and Vasa, M and Mildner-Rihm, C and Adler, K and Tiemann, M and Rutten, H and Fichtlscherer, S and Martin, H and Zeiher, A. (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway Journal of Clinical Investigation, 108, pp. 391-397. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
12. Dimmeler, S and Zeiher, A. (1999) Nitric oxide-an endothelial cell survival factor Cell Death and Differentiation, 6, pp. 964-968. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
13. Dulak, J and Jozkowicz, A. (2003) Regulation of vascular endothelial growth factor synthesis by nitric oxide: Facts and controversies Antioxidants and Redox Signaling, 5, pp. 123-132. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
14. Dulak, J and Jozkowicz, A and Foresti, R and Kasza, A and Frick, M and Huk, I and Green, C. and Pachinger, O and Weidinger, F and Motterlini, R. (2002) Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells Antioxidants and Redox Signaling, 4, pp. 229-240. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
15. Dulak, J and Jozkowicz, A and Frick, M and Alber, H. and Dichtl, W and Schwarzacher, S. and Pachinger, O and Weidinger, F. (2001) Vascular endothelial growth factor: Angiogenesis, atherogenesis or both? Journal of American College of Cardiology, 38, pp. 2137-2138. [CSA] [CROSSREF]
16. Dulak, J and Loboda, A and Zagorska, A and Jozkowicz, A. (2004) Complex role of heme oxygenase-1 in angiogenesis Antioxidants and Redox Signaling, 6, pp. 858-866. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
17. Frick, M and Dulak, J and Cisowski, J and Jozkowicz, A and Zwick, R and Alber, H and Dichtl, W and Schwarzacher, S. and Pachinger, O and Weidinger, F. (2003) Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells Atherosclerosis, 170, pp. 229-236. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
18. Heymans, S and Luttun, A and Nuyens, D and Theilmeier, G and Creemers, E and Moons, L and Dyspersin, G. and Cleutjens, J. and Shipley, M and Angellilo, A and Levi, M and Nube, O and Baker, A and Keshet, E and Lupu, F and Herbert, J. and Smits, J. and Shapiro, S. and Baes, M and Borgers, M and Collen, D and Daemen, M. and Carmeliet, P. (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure Nature Medicine, 5, pp. 1135-1142. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
19. Jozkowicz, A and Dulak, J and Prager, M and Nanobashvili, J and Nigisch, A and Winter, B and Weigel, G and Huk, I. (2001) Prostaglandin-J2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-gamma-independent manner Prostaglandins and Other Lipid Mediators, 66, pp. 165-177. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
20. Jozkowicz, A and Dulak, J and Nigisch, A and Funovics, P and Weigel, G and Polterauer, P and Huk, I and Malinski, T. (2004) Involvement of nitric oxide in angiogenic activities of vascular endothelial growth factor isoforms Growth Factors, 22, pp. 19-28. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
21. Józkowicz, A and Huk, I and Nigisch, A and Weigel, G and Dietrich, W and Motterlini, R and Dulak, J. (2003) Heme oxygenase and angiogenic activity of endothelial cells: Stimulation by carbon monoxide, inhibition by tin protoporphyrin-X Antioxidants and Redox Signaling, 5, pp. 155-162. [CSA] [CROSSREF]
22. Kaneta, S and Satoh, K and Kano, S and Kanda, M and Ichihara, K. (2003) All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells Atherosclerosis, 170, pp. 237-243. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
23. Kaushal, V and Kohli, M and Mehta, P and Mehta, J. (2003) Potential anticancer effect of statins: Fact or fiction Endothelium, 10, pp. 49-58. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
24. Korff, T and Augustin, H. (1998) Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation Journal of Cell Biology, 143, pp. 1341-1352. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
25. Kureishi, Y and Luo, Z and Shiojima, I and Bialik, A and Fulton, D and Lefer, D. and Sessa, W. and Walsh, K. (2000) The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals Nature Medicine, 6, pp. 1004-1010. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
26. Laderoute, K. and Alarcon, R. and Brody, M. and Calaoagan, J. and Chen, E. and Knapp, A. and Yun, Z and Denko, N. and Giaccia, A. (2000) Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor Clinical Cancer Research, 6, pp. 2941-2950. [PUBMED] [INFOTRIEVE] [CSA]
27. Laufs, U and Fata, V. and Liao, J. (1997) Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase Journal of Biological Chemistry, 272, pp. 31725-31729. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
28. Laufs, U and La Fata, V and Plutzky, J and Liao, J. (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation, 97, pp. 1129-1135. [PUBMED] [INFOTRIEVE] [CSA]
29. Lawler, J and Detmar, M. (2004) Tumor progression: The effects of thrombospondin-1 and -2 International Journal of Biochemistry and Cell Biology, 36, pp. 1038-1045. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
30. Lee, T. and Chang, C. and Zhu, Y and Shyy, J. (2004) Simvastatin induces heme oxygenase-1: A novel mechanism of vessel protection Circulation, 110, pp. 1296-1302. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
31. Lennernas, H. (2003) Clinical pharmacokinetics of atorvastatin Clinical Pharmacokinetics, 42, pp. 1141-1160. [PUBMED] [INFOTRIEVE] [CSA]
32. Li, A and Dubey, S and Varney, M. and Dave, B. and Singh, R. (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis Journal of Immunology, 170, pp. 3369-3376. [CSA]
33. Liao, J. and Laufs, U. (2004) Pleiotropic effects of statins Annual Reviews in Pharmacology and Toxicology, 45, pp. 89-118. Aug 17 [CSA] [CROSSREF]
34. Llevadot, J and Murasawa, S and Kureishi, Y and Uchida, S and Masuda, H and Kawamoto, A and Walsh, K and Isner, J. and Asahara, T. (2001) HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells Journal of Clinical Investigation, 108, pp. 399-405. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
35. Motegi, K and Harada, K and Pazouki, S and Baillie, R and Schor, A. (2002) Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis Histochemical Journal, 34, pp. 411-421. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
36. Moulton, K. and Heller, E and Konerding, M. and Flynn, E and Palinski, W and Folkman, J. (1999) Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice Circulation, 99, pp. 1726-1732. [PUBMED] [INFOTRIEVE] [CSA]
37. Moulton, K. and Vakili, K and Zurakowski, D and Soliman, M and Butterfield, C and Sylvin, E and Lo, K. and Gillies, S and Javaherian, K and Folkman, J. (2003) Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis Proceedings of the National Acadaemy of Sciences of the United States of America, 100, pp. 4736-4741. [CSA] [CROSSREF]
38. Muck, A. and Seeger, H and Wallwiener, D. (2004) Class-specific pro-apoptotic effect of statins on human vascular endothelial cells Zeischrift für Kardiologie, 93, pp. 398-402. [CSA] [CROSSREF]
39. Newton, C. and Xie, Y. and Burgoyne, C. and Adams, I and Atkin, S. and Abidia, A and McCollum, P. (2003) Fluvastatin induces apoptosis of vascular endothelial cells: Blockade by glucocorticoids Cardiovascular Surgery, 11, pp. 52-60. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
40. Phelan, M. and Forman, L. and Perrine, S. and Faller, D. (1998) Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells Journal of Laboratory and Clinical Medicine, 132, pp. 519-529. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
41. Rezaie-Majd, A and Prager, G. and Bucek, R. and Schernthaner, G. and Maca, T and Kress, H and Valent, P and Binder, B. and Minar, E and Baghestanian, M. (2003) Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients Arteriosclerosis, Thrombosis and Vascular Biology, 23, pp. 397-403. [CSA] [CROSSREF]
42. Rodriguez-Porcel, M and Lerman, A and Ritman, E. and Wilson, S. and Best, P. and Lerman, L. (2000) Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia Circulation, 102, pp. 2028-2030. [PUBMED] [INFOTRIEVE] [CSA]
43. Sata, M and Nishimatsu, H and Osuga, J and Tanaka, K and Ishizaka, N and Ishibashi, S and Hirata, Y and Nagai, R. (2004) Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis Hypertension, 43, pp. 1214-1220. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
44. Sata, M and Nishimatsu, H and Suzuki, E and Sugiura, S and Yoshizumi, M and Ouchi, Y and Hirata, Y and Nagai, R. (2001) Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia FASEB Journal, 15, pp. 2530-2532. [PUBMED] [INFOTRIEVE] [CSA]
45. Sikorski, E. and Hock, T and Hill-Kapturczak, N and Agarwal, A. (2004) The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury American Journal of Physiology Renal Physiology, 286, pp. F425-F441. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
46. Undas, A and Celinska-Lowenhoff, M and Kaczor, M and Musial, J. (2004) New nonlipid effects of statins and their clinical relevance in cardiovascular disease Thrombosis Haemostasis, 91, pp. 1065-1077. [CSA]
47. Urbich, C and Dernbach, E and Zeiher, A. and Dimmeler, S. (2002) Double-edged role of statins in angiogenesis signaling Circulation Research, 90, pp. 737-744. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
48. Waehre, T and Damas, J. and Gullestad, L and Holm, A. and Pedersen, T. and Arnesen, K. and Torsvik, H and Froland, S. and Semb, A. and Aukrust, P. (2003) Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease Journal of American College of Cardiology, 41, pp. 1460-1467. [CSA] [CROSSREF]
49. Wang-Rodriguez, J and Urquidi, V and Rivard, A and Goodison, S. (2003) Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status Breast Cancer Research, 5, pp. R136-R143. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
50. Wassmann, S and Nickening, G. (2003) Interrelationship of free radicals and endothelial dysfunction - modulation by statins Endothelium, 10, pp. 23-33. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
51. Weinstat-Saslow, D. and Zabrenetzky, V. and VanHoutte, K and Frazier, W. and Roberts, D. and Steeg, P. (1994) Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis Cancer Research, 54, pp. 6504-6511. [PUBMED] [INFOTRIEVE] [CSA]
52. Weis, M and Heeschen, C and Glassford, A. and Cooke, J. (2002) Statins have biphasic effects on angiogenesis Circulation, 105, pp. 739-745. [PUBMED] [INFOTRIEVE] [CSA]
53. Wiesbauer, F and Kaun, C and Zorn, G and Maurer, G and Huber, K and Wojta, J. (2002) HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: A comparative study using different statins British Journal of Pharmacology, 135, pp. 284-292. [PUBMED] [INFOTRIEVE] [CSA]
54. Wilson, S. and Herrmann, J and Lerman, L. and Holmes, D., Jr and Napoli, C and Ritman, E. and Lerman, A. (2002) Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering Circulation, 105, pp. 415-418. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
55. Wong, W. and Dimitroulakos, J and Minden, M. and Penn, L. (2002) HMG-CoA reductase inhibitors and the malignant cell: The statin family of drugs as triggers of tumor-specific apoptosis Leukemia, 16, pp. 508-519. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
56. Zachary, I and Gliki, G. (2001) Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family Cardiovascular Research, 49, pp. 568-581. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]